SPOTLIGHT -
As a result of efforts by the American Academy of Ophthalmology (AAO),the proposed Medicare fee schedule for 2002 includes new coverage for glaucomascreening, as well as increases in two ophthalmic services.
Aurion Biotech doses first Canadian patient in Phase 1/2 ABA-1, CLARA clinical trial of AURN001
EyePod: Modifier Gene Therapy: What is it?
Navigating ocular effects of cancer therapy: Insights from breast cancer and head-neck cancers
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
ABVC BioPharma reaches global licensing deal for ophthalmology pipeline
Plastic surgery: When specialties overlap